Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

China Pharma Holdings Net Profit Margin 2010-2023 | CPHI

China Pharma Holdings net profit margin from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
  
China Pharma Holdings Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2023-12-31 $0.01B $-0.00B -42.86%
2023-09-30 $0.01B $-0.00B -37.50%
2023-06-30 $0.01B $-0.00B -37.50%
2023-03-31 $0.01B $-0.00B -33.33%
2022-12-31 $0.01B $-0.00B -44.44%
2022-09-30 $0.01B $-0.00B -44.44%
2022-06-30 $0.01B $-0.00B -44.44%
2022-03-31 $0.01B $-0.00B -44.44%
2021-12-31 $0.01B $-0.00B -44.44%
2021-09-30 $0.01B $-0.00B -44.44%
2021-06-30 $0.01B $-0.00B -44.44%
2021-03-31 $0.01B $-0.00B -27.27%
2020-12-31 $0.01B $-0.00B -27.27%
2020-09-30 $0.01B $-0.02B -190.91%
2020-06-30 $0.01B $-0.02B -190.91%
2020-03-31 $0.01B $-0.02B -220.00%
2019-12-31 $0.01B $-0.02B -190.91%
2019-09-30 $0.01B $-0.01B -90.91%
2019-06-30 $0.01B $-0.01B -100.00%
2019-03-31 $0.01B $-0.01B -100.00%
2018-12-31 $0.01B $-0.01B -91.67%
2018-09-30 $0.01B $-0.02B -130.77%
2018-06-30 $0.01B $-0.02B -121.43%
2018-03-31 $0.01B $-0.02B -128.57%
2017-12-31 $0.01B $-0.02B -146.15%
2017-09-30 $0.01B $-0.01B -57.14%
2017-06-30 $0.01B $-0.01B -57.14%
2017-03-31 $0.02B $-0.01B -53.33%
2016-12-31 $0.02B $-0.01B -56.25%
2016-09-30 $0.02B $-0.02B -131.25%
2016-06-30 $0.02B $-0.02B -94.12%
2016-03-31 $0.02B $-0.01B -68.42%
2015-12-31 $0.02B $-0.02B -71.43%
2015-09-30 $0.02B $-0.02B -115.79%
2015-06-30 $0.02B $-0.03B -147.62%
2015-03-31 $0.02B $-0.04B -195.24%
2014-12-31 $0.02B $-0.04B -177.27%
2014-09-30 $0.03B $-0.03B -100.00%
2014-06-30 $0.03B $-0.02B -79.31%
2014-03-31 $0.03B $-0.02B -58.06%
2013-12-31 $0.03B $-0.02B -59.38%
2013-09-30 $0.04B $-0.01B -27.78%
2013-06-30 $0.04B $-0.01B -17.50%
2013-03-31 $0.05B $-0.00B -2.13%
2012-12-31 $0.06B $0.01B 9.09%
2012-09-30 $0.07B $0.01B 15.38%
2012-06-30 $0.07B $0.01B 18.92%
2012-03-31 $0.08B $0.02B 21.52%
2011-12-31 $0.08B $0.02B 23.46%
2011-09-30 $0.08B $0.02B 26.51%
2011-06-30 $0.08B $0.02B 28.40%
2011-03-31 $0.08B $0.02B 30.77%
2010-12-31 $0.08B $0.02B 32.00%
2010-09-30 $0.07B $0.02B 28.17%
2010-06-30 $0.07B $0.02B 30.88%
2010-03-31 $0.07B $0.02B 29.23%
2009-12-31 $0.06B $0.02B 28.57%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.005B $0.007B
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.751B 5.69
Dr Reddy's Laboratories (RDY) India $12.261B 19.39
Aspen Pharmacare (APNHY) South Africa $5.328B 0.00
BridgeBio Pharma (BBIO) United States $4.794B 0.00
Bausch Health Cos (BHC) Canada $3.201B 2.50
Amphastar Pharmaceuticals (AMPH) United States $2.016B 13.80
Supernus Pharmaceuticals (SUPN) United States $1.655B 0.00
Taysha Gene Therapies (TSHA) United States $0.454B 0.00
Generation Bio (GBIO) United States $0.188B 0.00
Personalis (PSNL) United States $0.074B 0.00
Assembly Biosciences (ASMB) United States $0.068B 0.00
Acasti Pharma (ACST) Canada $0.026B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00